Page last updated: 2024-08-24

halofuginone and 2019 Novel Coronavirus Disease

halofuginone has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alfaras, I; Camarco, DP; Chen, BB; Chen, Y; Evankovich, JW; Finkel, T; Kennerdell, JR; Larsen, MB; Lear, TB; Lin, B; Liu, J; Liu, Y; Lockwood, KC; McDyer, JF; Myerburg, MM; Salminen, L; Tuncer, F	1

Other Studies

1 other study(ies) available for halofuginone and 2019 Novel Coronavirus Disease

Article	Year
A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry. Nature communications, 2021, 06-23, Volume: 12, Issue:1 Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization	2021

Article

Year

A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.

Nature communications, 2021, 06-23, Volume: 12, Issue:1

Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization

2021